# SANOVO (NCT05009836)

> Clinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05009836
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Hutchmed
- Conditions: Non-small Cell Lung Cancer
- Interventions: Savolitinib; Placebo; Osimertinib
- Enrollment: 412
- Primary outcome: PFS

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 8

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=sanovo-nct05009836

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05009836", "email": "<work email>"}; the inbox owner confirms by the emailed link.